-
★
Predictors of Nonseroconversion after SARS-CoV-2 Infection
(Hinzugefügt: 15.09.2021 um 15:01 Uhr)
https://wwwnc.cdc.gov/eid/article/27/9/21-1042_article
-
Nucleocapsid and spike antibody responses following virologically confirmed SARS-CoV-2 infection: an observational analysis in the Virus Watch community cohort
(Hinzugefügt: 06.12.2022 um 16:59 Uhr)
https://www.sciencedirect.com/science/article/pii/S1201971222004490
-
Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C
(Hinzugefügt: 06.06.2022 um 09:04 Uhr)
https://www.nature.com/articles/s41467-022-30649-1
-
Longitudinal Analysis of Coronavirus-Neutralizing Activity in COVID-19 Patients
(Hinzugefügt: 27.05.2022 um 07:48 Uhr)
https://www.mdpi.com/1999-4915/14/5/882/htm
-
Omicron sub-lineages BA.4/BA.5 escape BA.1 infection elicited neutralizing immunity
(Hinzugefügt: 13.05.2022 um 08:32 Uhr)
https://www.medrxiv.org/content/10.1101/2022.04.29.22274477v1
-
Neutralization Profile after Recovery from SARS-CoV-2 Omicron Infection
(Hinzugefügt: 27.03.2022 um 08:00 Uhr)
https://www.nejm.org/doi/full/10.1056/NEJMc2201607
-
SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study
(Hinzugefügt: 26.03.2022 um 11:21 Uhr)
https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(22)00036-2/fulltext
-
Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity
(Hinzugefügt: 22.03.2022 um 16:00 Uhr)
https://www.cell.com/cell/pdf/S0092-8674(22)00328-2.pdf?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0092867422003282%3Fshowall%3Dtrue
-
Characterization of the immune resistance of SARS-CoV-2 Mu variant and the robust immunity induced by Mu infection
(Hinzugefügt: 20.02.2022 um 12:25 Uhr)
https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiac053/6530359
-
Protection against the Omicron Variant from Previous SARS-CoV-2 Infection
(Hinzugefügt: 14.02.2022 um 16:22 Uhr)
https://www.nejm.org/doi/full/10.1056/NEJMc2200133
-
Immunity to SARS-CoV-2 up to 15 months after infection
(Hinzugefügt: 11.01.2022 um 10:12 Uhr)
https://www.cell.com/iscience/fulltext/S2589-0042(22)00013-X
-
Mapping the antigenic diversification of SARS-CoV-2
(Hinzugefügt: 10.01.2022 um 12:50 Uhr)
https://www.medrxiv.org/content/10.1101/2022.01.03.21268582v1
-
2 Omicron infection enhances neutralizing immunity against the Delta variant
(Hinzugefügt: 28.12.2021 um 14:36 Uhr)
https://secureservercdn.net/50.62.198.70/1mx.c5c.myftpupload.com/wp-content/uploads/2021/12/MEDRXIV-2021-268439v1-Sigal.pdf
-
Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection
(Hinzugefügt: 25.12.2021 um 15:22 Uhr)
https://www.biorxiv.org/content/10.1101/2021.12.20.473584v1
-
Omikron: RKI erhöht Risikoeinschätzung für zweifach Geimpfte und Genesene
(Hinzugefügt: 21.12.2021 um 12:50 Uhr)
https://www.aerzteblatt.de/nachrichten/130276/Omikron-RKI-erhoeht-Risikoeinschaetzung-fuer-zweifach-Geimpfte-und-Genesene
-
SARS-CoV-2 B.1.1.529 variant (Omicron) evades neutralization by sera from vaccinated and convalescent individuals
(Hinzugefügt: 21.12.2021 um 12:24 Uhr)
https://www.medrxiv.org/content/10.1101/2021.12.08.21267491v1
-
Omicron largely evades immunity from past infection or two vaccine doses
(Hinzugefügt: 20.12.2021 um 12:19 Uhr)
https://www.imperial.ac.uk/news/232698/modelling-suggests-rapid-spread-omicron-england/
-
Efficient mucosal antibody response to SARS-CoV-2 vaccination is induced in previously infected individuals
(Hinzugefügt: 13.12.2021 um 10:17 Uhr)
https://www.medrxiv.org/content/10.1101/2021.12.06.21267352v1
-
Duration of SARS-CoV-2 Natural Immunity and Protection against the Delta Variant: A Retrospective Cohort Study
(Hinzugefügt: 07.12.2021 um 07:11 Uhr)
https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab999/6448857
-
An immune correlate of SARS-CoV-2 infection and severity of reinfections
(Hinzugefügt: 26.11.2021 um 08:58 Uhr)
https://www.medrxiv.org/content/10.1101/2021.11.23.21266767v1
-
Durability of SARS-CoV-2 Antibodies from Natural Infection in Children and Adolescents
(Hinzugefügt: 25.11.2021 um 12:21 Uhr)
https://www.medrxiv.org/content/10.1101/2021.11.21.21266484v1
-
Humoral immune response after COVID-19 infection or BNT162b2 vaccine among older adults: evolution over time and protective thresholds.
(Hinzugefügt: 20.11.2021 um 10:30 Uhr)
https://www.medrxiv.org/content/10.1101/2021.11.19.21266252v1
-
Protective immunity after recovery from SARS-CoV-2 infection
(Hinzugefügt: 19.11.2021 um 20:19 Uhr)
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00676-9/fulltext
-
COVID-19 antibodies remain in the body 10 months after infection
(Hinzugefügt: 01.11.2021 um 10:01 Uhr)
https://www.kcl.ac.uk/news/covid-19-antibodies-remain-in-the-body-10-months-after-infection
-
Equivalency of Protection from Natural Immunity in COVID-19 Recovered Versus Fully Vaccinated Persons: A Systematic Review and Pooled Analysis
(Hinzugefügt: 29.10.2021 um 13:46 Uhr)
https://www.medrxiv.org/content/10.1101/2021.09.12.21263461v1
-
A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy
(Hinzugefügt: 18.10.2021 um 10:20 Uhr)
https://www.biorxiv.org/content/10.1101/2021.10.12.464114v1
-
The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study
(Hinzugefügt: 02.10.2021 um 18:07 Uhr)
https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(21)00219-6/fulltext
-
High affinity memory B cells induced by SARS-CoV-2 infection produce more plasmablasts and atypical memory B cells than those primed by mRNA vaccines
(Hinzugefügt: 26.09.2021 um 08:21 Uhr)
https://www.cell.com/cell-reports/fulltext/S2211-1247(21)01287-0
-
The longitudinal kinetics of antibodies in COVID-19 recovered patients over 14 months
(Hinzugefügt: 22.09.2021 um 10:26 Uhr)
https://www.medrxiv.org/content/10.1101/2021.09.16.21263693v1
-
Having SARS-CoV-2 once confers much greater immunity than a vaccine—but vaccination remains vital
(Hinzugefügt: 15.09.2021 um 15:48 Uhr)
https://www.science.org/content/article/having-sars-cov-2-once-confers-much-greater-immunity-vaccine-vaccination-remains-vital
-
Having SARS-CoV-2 once confers much greater immunity than a vaccine—but no infection parties, please
(Hinzugefügt: 28.08.2021 um 13:40 Uhr)
https://www.sciencemag.org/news/2021/08/having-sars-cov-2-once-confers-much-greater-immunity-vaccine-no-infection-parties
-
Long-term Persistence of Neutralizing Antibodies to SARS-CoV-2 Following Infection
(Hinzugefügt: 24.08.2021 um 17:24 Uhr)
https://link.springer.com/article/10.1007/s11606-021-07057-0
-
Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells
(Hinzugefügt: 24.07.2021 um 15:25 Uhr)
https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(21)00203-2
-
SARS-CoV-2: Antikörper persistieren mindestens 9 Monate
(Hinzugefügt: 20.07.2021 um 11:02 Uhr)
https://www.aerzteblatt.de/nachrichten/125703/SARS-CoV-2-Antikoerper-persistieren-mindestens-9-Monate
-
SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity
(Hinzugefügt: 30.06.2021 um 15:02 Uhr)
https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(21)00203-6/fulltext
-
Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection
(Hinzugefügt: 23.06.2021 um 18:08 Uhr)
https://www.nature.com/articles/s41586-021-03696-9
-
Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection
(Hinzugefügt: 20.06.2021 um 18:04 Uhr)
https://www.nature.com/articles/s41586-021-03696-9
-
A long-term perspective on immunity to COVID
(Hinzugefügt: 20.06.2021 um 18:00 Uhr)
https://www.nature.com/articles/d41586-021-01557-z
-
A long-term perspective on immunity to COVID
(Hinzugefügt: 20.06.2021 um 17:55 Uhr)
https://www.nature.com/articles/d41586-021-01557-z
-
Incidence of SARS-CoV-2 infection according to baseline antibody status in staff and residents of 100 long-term care facilities (VIVALDI): a prospective cohort study
(Hinzugefügt: 20.06.2021 um 17:45 Uhr)
https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(21)00093-3/fulltext
-
COVID-19 Immunity: If I Had COVID, Am I Immune?
(Hinzugefügt: 13.06.2021 um 16:39 Uhr)
https://painresource.com/covid-19/covid-19-immunity-if-i-had-covid-am-i-immune/
-
Covid-19: Genesene könnten ein Leben lang immun sein
(Hinzugefügt: 11.06.2021 um 06:55 Uhr)
https://www.aponet.de/artikel/covid-19-genesene-koennten-ein-leben-lang-immun-sein-24271
-
Antibody longevity and cross-neutralizing activity following SARS–CoV–2 wave 1 and B.1.1.7 infections
(Hinzugefügt: 09.06.2021 um 19:19 Uhr)
https://www.medrxiv.org/content/10.1101/2021.06.07.21258351v1
-
Had COVID? You’ll probably make antibodies for a lifetime
(Hinzugefügt: 31.05.2021 um 17:50 Uhr)
https://www.nature.com/articles/d41586-021-01442-9
-
Good news: Mild COVID-19 induces lasting antibody protection
(Hinzugefügt: 26.05.2021 um 08:54 Uhr)
https://medicine.wustl.edu/news/good-news-mild-covid-19-induces-lasting-antibody-protection/
-
SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans
(Hinzugefügt: 25.05.2021 um 13:45 Uhr)
https://www.nature.com/articles/s41586-021-03647-4.epdf
-
Anti-SARS-CoV-2 Antibodies Persist for up to 13 Months and Reduce Risk of Reinfection
(Hinzugefügt: 20.05.2021 um 06:36 Uhr)
https://www.medrxiv.org/content/10.1101/2021.05.07.21256823v3
-
Corona-Studie Erlanger Forscher zu Covid-19: Abwehrkraft des Darms reicht nicht aus - Folgen für Impfungen?
(Hinzugefügt: 16.05.2021 um 10:43 Uhr)
https://www.infranken.de/lk/erlangenhoechstadt/covid-19-forscher-aus-erlangen-abwehrkraft-darm-nicht-ausreichend-bedeutung-fuer-impfungen-art-5206093
-
Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to eight months post-symptom onset
(Hinzugefügt: 06.05.2021 um 09:21 Uhr)
https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(21)00118-X
-
Estimating the cumulative incidence of SARS-CoV-2 infection and the infection fatality ratio in light of waning antibodies
(Hinzugefügt: 06.05.2021 um 09:10 Uhr)
https://journals.lww.com/epidem/abstract/9000/estimating_the_cumulative_incidence_of_sars_cov_2.98272.aspx
-
Some patients do not develop immunity after covid vaccination
(Hinzugefügt: 04.05.2021 um 05:30 Uhr)
https://sundhedspolitisktidsskrift.dk/nyheder/4792-nogle-patienter-udvikler-ikke-immunitet-efter-covid-vaccination.html
-
SARS-CoV-2 immunity and HIV infection: total recall?
(Hinzugefügt: 30.04.2021 um 05:42 Uhr)
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00097-7/fulltext
-
Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans
(Hinzugefügt: 30.04.2021 um 05:39 Uhr)
https://www.cell.com/cell-host-microbe/fulltext/S1931-3128(21)00191-8
-
SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy
(Hinzugefügt: 29.04.2021 um 07:19 Uhr)
https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(21)00141-3/fulltext
-
SARS-CoV-2 natural antibody response persists up to 12 months in a nationwide study from the Faroe Islands
(Hinzugefügt: 23.04.2021 um 12:18 Uhr)
https://www.medrxiv.org/content/10.1101/2021.04.19.21255720v1
-
Correlates of protection from SARS-CoV-2 infection
(Hinzugefügt: 18.04.2021 um 07:48 Uhr)
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00782-0/fulltext#.YHm1XY6bjXo.twitter
-
Past COVID-19 Infection Does Not Fully Protect Young People Against Reinfection, Study Shows
(Hinzugefügt: 17.04.2021 um 10:11 Uhr)
https://www.mountsinai.org/about/newsroom/2021/past-covid19-infection-does-not-fully-protect-young-people-against-reinfection-study-shows
-
SARS-CoV-2 Antibody Response in Persons with Past Natural Infection
(Hinzugefügt: 17.04.2021 um 09:56 Uhr)
https://www.nejm.org/doi/full/10.1056/NEJMc2103825
-
Rheinland-Studie: Antikörperschutz lässt nach Infektion schnell nach
(Hinzugefügt: 15.04.2021 um 06:10 Uhr)
https://www.aerzteblatt.de/nachrichten/122965/Rheinland-Studie-Antikoerperschutz-laesst-nach-Infektion-schnell-nach
-
SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)
(Hinzugefügt: 10.04.2021 um 05:44 Uhr)
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00675-9/fulltext
-
Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection
(Hinzugefügt: 06.04.2021 um 07:05 Uhr)
https://pubmed.ncbi.nlm.nih.gov/33625463/
-
Rapid decline of neutralizing antibodies is associated with decay of IgM in adults recovered from mild COVID-19 disease
(Hinzugefügt: 06.04.2021 um 06:41 Uhr)
https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(21)00069-0
-
SARS-CoV-2: Antikörper könnten über viele Jahre schützen (oder nur wenige Tage)
(Hinzugefügt: 26.03.2021 um 07:58 Uhr)
https://www.aerzteblatt.de/nachrichten/122393/SARS-CoV-2-Antikoerper-koennten-ueber-viele-Jahre-schuetzen-(oder-nur-wenige-Tage)
-
Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains
(Hinzugefügt: 03.03.2021 um 08:34 Uhr)
https://www.biorxiv.org/content/10.1101/2021.03.01.433314v1
-
Evolution of SARS-CoV-2 antibody immunity
(Hinzugefügt: 03.03.2021 um 08:24 Uhr)
https://www.microbe.tv/immune/
-
Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection
(Hinzugefügt: 25.02.2021 um 20:04 Uhr)
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2776810?guestAccessKey=3e87dda5-1626-4a94-8716-5b73e3534d44&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=022421
-
SARS‐CoV‐2 re‐infection risk in Austria
(Hinzugefügt: 25.02.2021 um 19:26 Uhr)
https://onlinelibrary.wiley.com/doi/full/10.1111/eci.13520
-
COVID-19: Nach durchlebter Erkrankung ähnlicher Schutz wie durch Impfung
(Hinzugefügt: 25.02.2021 um 19:25 Uhr)
https://www.heilpraxisnet.de/naturheilpraxis/covid-19-nach-durchlebter-erkrankung-aehnlicher-schutz-wie-durch-impfung-20210223533417/
-
Prolonged evolution of the human B cell response to SARS-CoV-2 infection
(Hinzugefügt: 24.02.2021 um 08:46 Uhr)
https://immunology.sciencemag.org/content/6/56/eabg6916.full
-
Immunität gegen SARS-CoV-2 in Ischgl stabil
(Hinzugefügt: 19.02.2021 um 10:08 Uhr)
https://www.aerzteblatt.de/nachrichten/121308/Immunitaet-gegen-SARS-CoV-2-in-Ischgl-stabil
-
RKI-Studie: Antikörper nach einiger Zeit oft nicht nachweisbar
(Hinzugefügt: 19.02.2021 um 10:08 Uhr)
https://www.aerzteblatt.de/nachrichten/121275/RKI-Studie-Antikoerper-nach-einiger-Zeit-oft-nicht-nachweisbar
-
Corona-Monitoring lokal Eckdaten für Berlin-Mitte
(Hinzugefügt: 18.02.2021 um 10:02 Uhr)
https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/Dokumente/Factsheet_Berlin-Mitte.pdf?__blob=publicationFile
-
RKI-Studie 48 Prozent der Corona-Positiven in Berlin-Mitte haben keine Antikörper
(Hinzugefügt: 18.02.2021 um 10:00 Uhr)
https://www.spiegel.de/wissenschaft/medizin/coronavirus-48-prozent-der-corona-positiven-in-berlin-mitte-haben-keine-antikoerper-a-6874c3f3-7b75-49dd-9d3b-af18b9d26eb3-amp?utm_source=upday&utm_medium=referral
-
Antibodies to SARS-CoV-2 protect against re-infection during outbreaks in care homes, September and October 2020
(Hinzugefügt: 18.02.2021 um 08:18 Uhr)
https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2021.26.5.2100092
-
Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers
(Hinzugefügt: 09.02.2021 um 09:14 Uhr)
https://www.nature.com/articles/s41467-021-21111-9
-
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
(Hinzugefügt: 06.02.2021 um 09:26 Uhr)
https://science.sciencemag.org/content/371/6529/eabf4063.full
-
Maturation and persistence of the anti-SARS-CoV-2 memory B cell response.
(Hinzugefügt: 02.02.2021 um 19:55 Uhr)
https://www.cell.com/cell/fulltext/S0092-8674(21)00093-3
-
Stable neutralizing antibody levels six months after mild and severe COVID-19 episode
(Hinzugefügt: 01.02.2021 um 08:43 Uhr)
https://www.cell.com/med/fulltext/S2666-6340(21)00035-0
-
SARS-CoV-2 neutralizing antibodies; longevity, breadth, and evasion by emerging viral variants
(Hinzugefügt: 30.01.2021 um 11:24 Uhr)
https://www.medrxiv.org/content/10.1101/2020.12.19.20248567v2
-
Warten auf die Impfung Ein Jahr nach erstem Covid-Fall: Deutschlands Patient 1 hat keine Antikörper mehr
(Hinzugefügt: 28.01.2021 um 18:16 Uhr)
https://www.focus.de/gesundheit/news/warten-auf-die-impfung-ein-jahr-nach-erstem-corona-fall-deutschlands-patient-1-hat-keine-antikoerper-mehr_id_12916871.html
-
Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset
(Hinzugefügt: 26.01.2021 um 12:49 Uhr)
https://www.biorxiv.org/content/10.1101/2021.01.25.428097v1
-
SARS-CoV-2: Laborexperimente deuten auf verminderte Schutzwirkung gegen neue Varianten hin
(Hinzugefügt: 21.01.2021 um 19:23 Uhr)
https://www.aerzteblatt.de/nachrichten/120379/SARS-CoV-2-Laborexperimente-deuten-auf-verminderte-Schutzwirkung-gegen-neue-Varianten-hin
-
Nach Corona-Erkrankung: Forscher melden verblüffende Folge von Immunität - und appellieren an Bevölkerung
(Hinzugefügt: 20.01.2021 um 08:48 Uhr)
https://www.merkur.de/welt/coronavirus-immun-infiziert-forscher-studie-immunitaet-verblueffend-folgen-appell-warnung-zr-90173878.html
-
Memory B Cells, Infection, and Vaccination
(Hinzugefügt: 20.01.2021 um 08:35 Uhr)
https://blogs.sciencemag.org/pipeline/archives/2021/01/19/memory-b-cells-infection-and-vaccination
-
Evolution of antibody immunity to SARS-CoV-2
(Hinzugefügt: 18.01.2021 um 21:07 Uhr)
https://www.nature.com/articles/s41586-021-03207-w
-
Orthogonal immunoassays for IgG antibodies to SARS-CoV-2 antigens reveal that immune response lasts beyond 4 mo post illness onset
(Hinzugefügt: 17.01.2021 um 07:34 Uhr)
https://www.pnas.org/content/118/5/e2021615118
-
Recovering from Covid gives similar level of protection to vaccine
(Hinzugefügt: 14.01.2021 um 08:54 Uhr)
https://www.theguardian.com/society/2021/jan/14/recovering-from-covid-gives-similar-level-of-protection-to-vaccine
-
Health Workers’ Antibody Levels Wane After SARS-CoV-2 Infection
(Hinzugefügt: 14.01.2021 um 05:07 Uhr)
https://jamanetwork.com/journals/jama/fullarticle/2774845
-
Adaptive immunity to SARS-CoV-2 and COVID-19
(Hinzugefügt: 12.01.2021 um 20:32 Uhr)
https://www.cell.com/cell/fulltext/S0092-8674(21)00007-6?rss=yes
-
Stereotypic neutralizing VH antibodies against SARS-CoV-2 spike protein receptor binding domain in COVID-19 patients and healthy individuals
(Hinzugefügt: 11.01.2021 um 08:24 Uhr)
https://stm.sciencemag.org/content/early/2021/01/05/scitranslmed.abd6990.full
-
Adaptive immune responses to SARS-CoV-2 in recovered severe COVID-19 patients
(Hinzugefügt: 07.01.2021 um 05:00 Uhr)
https://www.medrxiv.org/content/10.1101/2021.01.05.20249027v1
-
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
(Hinzugefügt: 07.01.2021 um 04:59 Uhr)
https://science.sciencemag.org/content/early/2021/01/05/science.abf4063.full
-
SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection
(Hinzugefügt: 06.01.2021 um 08:27 Uhr)
https://www.medrxiv.org/content/10.1101/2021.01.03.21249162v1
-
Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection
(Hinzugefügt: 05.01.2021 um 08:14 Uhr)
https://www.journalofinfection.com/article/S0163-4453(20)30781-7/fulltext
-
Covid-19: Immunität hält mindestens acht Monate an
(Hinzugefügt: 30.12.2020 um 10:05 Uhr)
https://www.aponet.de/artikel/covid-19-immunitaet-haelt-mindestens-8-monate-an-22289
-
SARS-CoV-2: Gedächtniszellen erhalten Immunität über mindestens 8 Monate
(Hinzugefügt: 28.12.2020 um 19:04 Uhr)
https://www.aerzteblatt.de/nachrichten/119712/SARS-CoV-2-Gedaechtniszellen-erhalten-Immunitaet-ueber-mindestens-8-Monate
-
Study finds evidence of lasting immunity after mild or asymptomatic COVID-19 infection
(Hinzugefügt: 28.12.2020 um 08:49 Uhr)
https://medicalxpress.com/news/2020-12-evidence-immunity-mild-asymptomatic-covid-.html
-
Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence
(Hinzugefügt: 23.12.2020 um 08:27 Uhr)
https://immunology.sciencemag.org/content/5/54/eabf8891.full
-
Real-world data suggest antibody positivity to SARS-CoV-2 is associated with a decreased risk of future infection
(Hinzugefügt: 22.12.2020 um 08:04 Uhr)
https://www.medrxiv.org/content/10.1101/2020.12.18.20248336v1
-
T cell memory: Understanding COVID-19
(Hinzugefügt: 21.12.2020 um 17:18 Uhr)
https://www.cell.com/action/showPdf?pii=S1074-7613%2820%2930537-9
-
Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection
(Hinzugefügt: 16.12.2020 um 19:06 Uhr)
https://www.frontiersin.org/articles/10.3389/fimmu.2020.611337/full
-
Evaluation of SARS-CoV-2 neutralization assays for antibody monitoring in natural infection and vaccine trials
(Hinzugefügt: 09.12.2020 um 00:16 Uhr)
https://www.medrxiv.org/content/10.1101/2020.12.07.20245431v1
-
Correlates of protection against SARS-CoV-2 in rhesus macaques
(Hinzugefügt: 09.12.2020 um 00:14 Uhr)
https://www.nature.com/articles/s41586-020-03041-6
-
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
(Hinzugefügt: 05.12.2020 um 15:36 Uhr)
https://science.sciencemag.org/content/370/6521/1227.full
-
Airway antibodies wane rapidly after COVID-19 but B cell memory is generated across disease severity
(Hinzugefügt: 30.11.2020 um 09:00 Uhr)
https://www.medrxiv.org/content/10.1101/2020.11.25.20238592v1
-
Decline in SARS-CoV-2 Antibodies After Mild Infection
(Hinzugefügt: 28.11.2020 um 09:37 Uhr)
https://www.cdc.gov/mmwr/volumes/69/wr/mm6947a2.htm
-
Antibodies, Immunity, and COVID-19
(Hinzugefügt: 27.11.2020 um 10:48 Uhr)
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2773575
-
Functional SARS-CoV-2-specific immune memory persists after mild COVID-19
(Hinzugefügt: 24.11.2020 um 09:20 Uhr)
https://www.cell.com/cell/fulltext/S0092-8674(20)31565-8
-
Rapid and lasting generation of B-cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 disease and convalescence
(Hinzugefügt: 21.11.2020 um 09:23 Uhr)
https://www.medrxiv.org/content/10.1101/2020.11.17.20233544v1
-
Coronavirus antibody prevalence falling in England, REACT study show
(Hinzugefügt: 20.11.2020 um 08:21 Uhr)
https://www.imperial.ac.uk/news/207333/coronavirus-antibody-prevalence-falling-england-react/
-
Immunological memory to SARS-CoV-2 assessed for greater than six months after infection
(Hinzugefügt: 18.11.2020 um 09:12 Uhr)
https://www.biorxiv.org/content/10.1101/2020.11.15.383323v1
-
Estimating the cumulative incidence of SARS-CoV-2 infection and the infection fatality ratio in light of waning antibodies
(Hinzugefügt: 17.11.2020 um 08:50 Uhr)
https://www.medrxiv.org/content/10.1101/2020.11.13.20231266v1
-
Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cells
(Hinzugefügt: 16.11.2020 um 12:28 Uhr)
https://www.nature.com/articles/s41591-020-01143-2
-
Immunologisches Gedächtnis nach ausgeheilter Sars-CoV-2-Infektion
(Hinzugefügt: 16.11.2020 um 12:28 Uhr)
https://www.uniklinik-freiburg.de/presse/pressemitteilungen/detailansicht/2258-immunologisches-gedaechtnis-nach-ausgeheilter-sars-cov-2-infektion.html
-
Nach 4 Berichten zu Re-Infektionen: Wie lange hält eine Immunität
(Hinzugefügt: 03.11.2020 um 15:01 Uhr)
https://www.aerzteblatt.de/nachrichten/116059/Nach-4-Berichten-zu-Re-Infektionen-Wie-lange-haelt-eine-Immunitaet-gegen-SARS-CoV-2-an
-
six months in non-hospitalised individuals
(Hinzugefügt: 02.11.2020 um 18:48 Uhr)
https://www.uk-cic.org/news/cellular-immunity-sars-cov-2-found-six-months-non-hospitalised-individuals
-
Antikörper nach Monaten noch nachweisbar
(Hinzugefügt: 01.11.2020 um 15:56 Uhr)
https://www.aerzteblatt.de/nachrichten/117289/COVID-19-Protektive-Antikoerper-auch-nach-Monaten-noch-in-Blut-und-Speichel-nachweisbar
-
Impfschutz auch bei unzureichender natürlicher Immunität
(Hinzugefügt: 01.11.2020 um 15:56 Uhr)
https://www.aerzteblatt.de/nachrichten/117802/SARS-CoV-2-Impfschutz-auch-bei-unzureichender-natuerlicher-Immunitaet-moeglich
-
robuste Antikörperantwort über mindestens 5 Monate
(Hinzugefügt: 01.11.2020 um 15:56 Uhr)
https://www.aerzteblatt.de/nachrichten/117827/COVID-19-Studie-findet-robuste-Antikoerperantwort-ueber-mindestens-5-Monate
-
antibodies persist for months
(Hinzugefügt: 01.11.2020 um 15:56 Uhr)
https://science.sciencemag.org/content/early/2020/10/27/science.abd7728.full
-
REACT Studie England
(Hinzugefügt: 01.11.2020 um 15:56 Uhr)
https://www.imperial.ac.uk/news/207333/coronavirus-antibody-prevalence-falling-england-react/
-
Cerebrospinal fluid findings
(Hinzugefügt: 01.11.2020 um 15:56 Uhr)
https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(20)30147-6/fulltext
-
TZellen
(Hinzugefügt: 01.11.2020 um 15:56 Uhr)
https://www.nature.com/articles/s41590-020-0798-y
-
Rückgang Seroprävalenz
(Hinzugefügt: 01.11.2020 um 15:56 Uhr)
https://www.aerzteblatt.de/nachrichten/117766/Schneller-Rueckgang-der-Seropraevalenz-nach-erster-COVID-19-Welle-in-England
-
TZellen
(Hinzugefügt: 01.11.2020 um 15:56 Uhr)
https://www.cebm.net/covid-19/what-is-the-role-of-t-cells-in-covid-19-infection-why-immunity-is-about-more-than-antibodies/
-
Antikörper im zeitlichen Verlauf
(Hinzugefügt: 01.11.2020 um 15:56 Uhr)
https://www.aerzteblatt.de/archiv/216359/COVID-19-Impfstoffe-Zwischen-Vision-und-Illusion
-
antibodies in people with loss of smell/taste
(Hinzugefügt: 01.11.2020 um 15:56 Uhr)
https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1003358
-
increased mortality by multiple exposures
(Hinzugefügt: 01.11.2020 um 15:56 Uhr)
https://www.medrxiv.org/content/10.1101/2020.10.22.20217638v1
-
Antikörper bei medizinischem Personal in UK
(Hinzugefügt: 01.11.2020 um 15:56 Uhr)
https://www.medrxiv.org/content/10.1101/2020.09.18.20197590v1
-
Antikörper nach 6 Monaten
(Hinzugefügt: 01.11.2020 um 15:56 Uhr)
https://onlinelibrary.wiley.com/doi/10.1002/eji.202048970
-
Immunität?
(Hinzugefügt: 01.11.2020 um 15:56 Uhr)
https://www.spiegel.de/wissenschaft/medizin/corona-infektion-von-donald-trump-das-immunitaetsraetsel-a-18e75f0f-7b00-4f36-b929-8160cb8c63ef?sara_ecid=soci_upd_KsBF0AFjflf0DZCxpPYDCQgO1dEMph
-
antibody mediated immunity
(Hinzugefügt: 01.11.2020 um 15:56 Uhr)
https://www.nature.com/articles/s41467-020-18450-4